Literature DB >> 27169535

End-Expiratory Lung Volume in Patients with Acute Respiratory Distress Syndrome: A Time Course Analysis.

Armin Kalenka1,2, Felix Gruner3, Christel Weiß4, Tim Viergutz3.   

Abstract

PURPOSE: Lung injury can be caused by ventilation and non-physiological lung stress (transpulmonary pressure) and strain [inflated volume over functional residual capacity ratio (FRC)]. FRC is severely decreased in patients with acute respiratory distress syndrome (ARDS). End-expiratory lung volume (EELV) is FRC plus lung volume increased by the applied positive end-expiratory pressure (PEEP). Measurement using the modified nitrogen multiple breath washout technique may help titrating PEEP during ARDS and allow determining dynamic lung strain (tidal volume over EELV) in patients ventilated with PEEP. In this observational study, we measured EELV for up to seven consecutive days in patients with ARDS at different PEEP levels.
RESULTS: Thirty sedated patients with ARDS (10 mild, 14 moderate, 6 severe) underwent decremental PEEP testing (20, 15, 10, 5 cm H2O) for up to 7 days after inclusion. At all PEEP levels examined, over a period of 7 days the measured absolute EELVs showed no significant change over time [PEEP 20 cm H2O 2464 ml at day 1 vs. 2144 ml at day 7 (p = 0.78), PEEP 15 cm H2O 2226 ml vs. 1990 ml (p = 0.36), PEEP 10 1835 ml vs. 1858 ml (p = 0.76) and PEEP 5 cm H2O 1487 ml vs. 1612 ml (p = 0.37)]. In relation to the predicted body weight (pbw), no significant change in EELV/kg pbw over time could be detected either at any PEEP level or over time [PEEP 20 36 ml/kg pbw at day 1 vs. 33 ml/kg pbw at day 7 (p = 0.66); PEEP 15 33 vs. 29 ml/kg pbw (p = 0.32); PEEP 10 27 vs. 27 ml/kg pbw (p = 0.70) and PEEP 5 22 vs. 24 ml/kg pbw (p = 0.70)]. Oxygenation significantly improved over time from PaO2/FiO2 of 169 mmHg at day 1 to 199 mmHg at day 7 (p < 0.01).
CONCLUSIONS: EELV did not change significantly for up to 7 days in patients with ARDS. By contrast, PaO2/FiO2 improved significantly. Bedside measurement of EELV may be a novel approach to individualise lung-protective ventilation on the basis of calculation of dynamic strain as the ratio of VT to EELV.

Entities:  

Keywords:  Acute respiratory distress syndrome; End-expiratory lung volume; Lung strain

Mesh:

Substances:

Year:  2016        PMID: 27169535     DOI: 10.1007/s00408-016-9892-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  30 in total

Review 1.  Which is the most important strain in the pathogenesis of ventilator-induced lung injury: dynamic or static?

Authors:  Alessandro Protti; Emiliano Votta; Luciano Gattinoni
Journal:  Curr Opin Crit Care       Date:  2014-02       Impact factor: 3.687

2.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.

Authors:  M B Amato; C S Barbas; D M Medeiros; R B Magaldi; G P Schettino; G Lorenzi-Filho; R A Kairalla; D Deheinzelin; C Munoz; R Oliveira; T Y Takagaki; C R Carvalho
Journal:  N Engl J Med       Date:  1998-02-05       Impact factor: 91.245

3.  Effect of local tidal lung strain on inflammation in normal and lipopolysaccharide-exposed sheep*.

Authors:  Tyler J Wellman; Tilo Winkler; Eduardo L V Costa; Guido Musch; R Scott Harris; Hui Zheng; Jose G Venegas; Marcos F Vidal Melo
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

4.  Lung regional metabolic activity and gas volume changes induced by tidal ventilation in patients with acute lung injury.

Authors:  Giacomo Bellani; Luca Guerra; Guido Musch; Alberto Zanella; Nicolò Patroniti; Tommaso Mauri; Cristina Messa; Antonio Pesenti
Journal:  Am J Respir Crit Care Med       Date:  2011-01-21       Impact factor: 21.405

Review 5.  Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R LeGall; A Morris; R Spragg
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

6.  Driving pressure and survival in the acute respiratory distress syndrome.

Authors:  Marcelo B P Amato; Maureen O Meade; Arthur S Slutsky; Laurent Brochard; Eduardo L V Costa; David A Schoenfeld; Thomas E Stewart; Matthias Briel; Daniel Talmor; Alain Mercat; Jean-Christophe M Richard; Carlos R R Carvalho; Roy G Brower
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

7.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

8.  Accuracy and precision of end-expiratory lung-volume measurements by automated nitrogen washout/washin technique in patients with acute respiratory distress syndrome.

Authors:  Jean Dellamonica; Nicolas Lerolle; Cyril Sargentini; Gaetan Beduneau; Fabiano Di Marco; Alain Mercat; Jean-Christophe M Richard; Jean-Luc Diehl; Jordi Mancebo; Jean-Jacques Rouby; Qin Lu; Gilles Bernardin; Laurent Brochard
Journal:  Crit Care       Date:  2011-12-07       Impact factor: 9.097

9.  Nitrogen washout/washin, helium dilution and computed tomography in the assessment of end expiratory lung volume.

Authors:  Davide Chiumello; Massimo Cressoni; Monica Chierichetti; Federica Tallarini; Marco Botticelli; Virna Berto; Cristina Mietto; Luciano Gattinoni
Journal:  Crit Care       Date:  2008-12-01       Impact factor: 9.097

Review 10.  Clinical review: bedside assessment of alveolar recruitment.

Authors:  Jean-Christophe Richard; Salvatore M Maggiore; Alain Mercat
Journal:  Crit Care       Date:  2003-10-22       Impact factor: 9.097

View more
  1 in total

Review 1.  Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal.

Authors:  Penny Andrews; Joseph Shiber; Maria Madden; Gary F Nieman; Luigi Camporota; Nader M Habashi
Journal:  Front Physiol       Date:  2022-07-25       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.